RePOSA, a global Phase 2/3 clinical trial is underway, evaluating IHL-42X in individuals with OSA who are either non-compliant, intolerant, or naïve to positive airway pressure devices, including ...

KeyBanc Capital Markets maintained its Overweight rating and $274.00 price target on ResMed (NYSE: RMD) stock following industry observations. The target aligns with broader analyst expectations, with ...

Background Obstructive sleep apnoea (OSA) can cause left atrial (LA) and left ventricular (LV) remodelling, which is linked to atrial fibrillation (AF). Whether continuous positive airway pressure ...

People with sleep apnea who use CPAP also report improved quality of life. In some observational studies that compare people with apnea who use CPAP versus those who don’t, the CPAP users have lower ...

Sleep apnea is a serious disorder that causes your breathing to stop repeatedly while you sleep. These breathing pauses or "apneas" usually last 10 to 30 seconds and can happen many times throughout ...

Objective To compare the efficacy of continuous positive airway pressure (CPAP) versus usual care for prehospital patients with severe respiratory distress. Methods We conducted a parallel group, ...